EGFR and adenocarcinoma: In a retrospective cohort study from South Korea, Shin et al. [27] found that among 314 patients with NSCLC adenocarcinoma who underwent MRI brain at diagnosis, there was a strong association between EGFR mutation status and brain metastasis (adjusted OR = 3.83, p = 0.001).